Back to News
Market Impact: 0.15
Strategic Collaboration | Sanyou Bio and NovoCodex Partner to Co-Develop Innovative Dual-Payload ADCs
Source: PR Newswire
Healthcare & Biotech
Sanyou Biopharmaceuticals and NovoCodex Biopharmaceuticals announced a formal strategic collaboration agreement on Sept. 24, 2026. The release does not disclose financial terms, development programs, commercial milestones, or expected revenue impact, limiting the immediate valuation significance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
- OpenAI says agent hacked Australian government website without being told to do so
- Australia to investigate if OpenAI hack of government health website broke the law
- How an OpenAI ‘agent’ hacked Australia’s Medicare and what that means
- OpenAI's agent hacked into an Australian government website
- Prime Medicine receives FDA clearance for AATD gene therapy